Knockout of Sf‐Caspase‐1 generates apoptosis‐resistant Sf9 cell lines: Implications for baculovirus expression. Issue 7 (22nd April 2022)

• Record Type: Journal Article
• Authors: de Malmanche, Henry; Marcellin, Esteban; Reid, Steven
• Is Part Of: Biotechnology journal. Volume 17:Issue 7(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-04-22
• Subjects: apoptosis -- baculovirus -- CRISPR‐Cas9 -- Sf9 -- Sf‐Caspase‐1; Biotechnology -- Periodicals; 660.605
• DOI: 10.1002/biot.202100532
• Languages: English
• ISSNs: 1860-6768

Abstract

Abstract: The Sf9 cell line, originally isolated from the insect Spodoptera frugiperda, is commonly used alongside the baculovirus expression vector system (BEVS) to produce recombinant proteins and other biologics. As more BEVS‐derived vaccines and therapeutics are approved by regulators and manufactured at scale, there is increasing interest in improving the Sf9 cell line to improve bioprocess robustness and increase product yields. CRISPR‐Cas9 is a powerful genome‐editing tool with great potential to improve cell line characteristics. Nevertheless, reports of genome‐editing in Sf9 cells are scarce, and targets for engineering are elusive. To evaluate the effectiveness of CRISPR‐Cas9 to improve BEVS yields, we generated Sf9 cell lines with functional knockouts in the Sf‐Caspase‐1 gene, which encodes an effector caspase involved in the execution of apoptosis. Deletion of Sf‐Caspase‐1 abolished the hallmarks of apoptotic cell death including plasma membrane blebbing and effector caspase activity. Following infection of Sf‐Caspase‐1 knockout Sf9 cultures with a recombinant baculovirus expressing β‐galactosidase, we did not observe any differences in cell death kinetics or increases in productivity. Similar results were obtained when Sf‐Caspase‐1 expression was suppressed via RNA interference. We anticipate that the CRISPR‐Cas9 workflow reported here will spur future efforts to rationally engineer Sf9 cells for improved baculovirus expression. Graphical Abstract and Lay Summary: The Sf9 cell line is widely used for the production of recombinant proteins and therapeutic biologics in conjunction with the baculovirus expression vector system. In this study, CRISPR/Cas9 was used to knockout Sf‐Caspase‐1, a gene involved in programmed cell death (apoptosis). Sf‐Caspase‐1 knockout cell lines were resistant to apoptosis but did not exhibit improvements in baculovirus expression using a model reporter construct.